gynecological oncology
Conditions
Interventions
treatment group:Acupoint injection of dexamethasone
control group:Acupoint injection of 0.9%NS
Sponsors
Changhai Hospital of Traditional Chinese Medicine, Shanghai
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) female, aged 18 to 70 years old; (2) diagnosed with gynecological tumors (ovarian, cervical, or endometrial cancer) based on pathology or cytology; (3) voluntary acceptance of the experimental treatment with informed consent, the informed consent process complied with GCP requirements; (4) Karnofsky scores higher than 60 points, with more than three months of expected survival and possible treatment with chemotherapy.
Exclusion criteria
Exclusion criteria: (1) diagnosis of functional damage to the liver, kidneys, or heart; (2) inability to follow the treatment because of regional mental abnormalities or pregnancy; (3) participating in other drug studies; (4) allergic constitution, has the history of drug allergy or known allergic to the medicine in the trial; (5) participation in other clinical trials in 3 months; (6) not sensitive or resistance th chemotherapy regimens; (7) using other drugs which could influence blood picture, anti-tumor or the immune function before starting the treatment; (8) the contraindications of dexamethasone: thrombosis, gastroduodenal ulcer, insanity and so on.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| white blood cell count; | — |
Secondary
| Measure | Time frame |
|---|---|
| nausea and vomiting;treament costs;the dosage of granulocyte colony-stimulating factor; | — |
Countries
China
Contacts
Public ContactYu Chaoqin
Shanghai Changhai Hospital
Outcome results
None listed